Pharmacological and Behavioral Characterization of D-473, an Orally Active Triple Reuptake Inhibitor Targeting Dopamine, Serotonin and Norepinephrine Transporters
Abstract
- Publication:
-
PLoS ONE
- Pub Date:
- November 2014
- DOI:
- 10.1371/journal.pone.0113420
- Bibcode:
- 2014PLoSO...9k3420D